Viewing Study NCT03573050


Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-25 @ 2:41 PM
Study NCT ID: NCT03573050
Status: COMPLETED
Last Update Posted: 2018-08-21
First Post: 2018-05-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase
Sponsor: SocraTec R&D GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module